Je. Shellito et al., REGULATION OF NITRIC-OXIDE RELEASE BY MACROPHAGES AFTER INTRATRACHEALLIPOPOLYSACCHARIDE, American journal of respiratory cell and molecular biology, 13(1), 1995, pp. 45-53
We investigated the effect of intratracheal (i.t.) lipopolysaccharide
(LPS) on alveolar macrophage release of nitric oxide. Mice received i.
t. LPS at doses ranging from 1 to 100 mu g/100 g body weight and were
killed at serial intervals for bronchoalveolar lavage. Control mice re
ceived i.t. phosphate-buffered saline. We found that after i.t. LPS, t
here was an early (1 to 3 days) influx of neutrophils followed by a la
ter (5 to 7 days) influx of macrophages into the lungs. Alveolar macro
phages lavaged from mice given i.t. LPS did not spontaneously release
nitric oxide (measured as nitrite), but the capacity of these cells to
release nitric oxide in vitro in response to interferon-gamma (IFN-ga
mma) or LPS was markedly upregulated. Alveolar macrophages lavaged fro
m mice given i.t. LPS but not i.t. phosphate-buffered saline also expr
essed mRNA for inducible nitric oxide synthase as measured by semiquan
titative reverse-transcription polymerase chain reaction. To investiga
te possible mechanisms for cellular priming for increased nitric oxide
release after i.t. LPS, mice were depleted of CD4(+) lymphocytes with
an anti-CD4 antibody, Alveolar macrophages from CD4-depleted mice giv
en i.t. LPS released significantly less nitric oxide in vitro in compa
rison to macrophages from nondepleted mice. Additional mice were treat
ed with neutralizing doses of anti-tumor necrosis factor or anti-IFN-g
amma antibody before i.t. LPS. Pretreatment with each cytokine antibod
y decreased but did not eliminate macrophage priming for nitric oxide
release after i.t. LPS. We conclude that intratracheal LPS induces mRN
A for nitric oxide synthase in alveolar macrophages; priming the cells
for increased release of nitric oxide in vitro. This alteration in al
veolar macrophage function is dependent upon host CD4(+) lymphocytes a
s well as the cytokines tumor necrosis factor and IFN-gamma.